Medtronic (MDT) Offering Possible 16.01% Return Over the Next 7 Calendar Days

This post was originally published on this site

Medtronic’s most recent trend suggests a bearish bias. One trading opportunity on Medtronic is a Bear Call Spread using a strike $128.00 short call and a strike $133.00 long call offers a potential 16.01% return on risk over the next 7 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $128.00 by expiration. The full premium credit of $0.69 would be kept by the premium seller. The risk of $4.31 would be incurred if the stock rose above the $133.00 long call strike price.

The 5-day moving average is moving down which suggests that the short-term momentum for Medtronic is bearish and the probability of a decline in share price is higher if the stock starts trending.

The 20-day moving average is moving down which suggests that the medium-term momentum for Medtronic is bearish.

The RSI indicator is at 33.8 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here


LATEST NEWS for Medtronic

Medtronic Expands Recall of MiniMed 600 Series Insulin Pumps
Wed, 06 Oct 2021 19:44:28 +0000
The FDA has announced that Medtronic Plc (NYSE: MDT) has expanded the Class I recall of its MiniMed 600 series insulin pumps. Medtronic is offering to replace all MiniMed 600 series insulin pumps that have a clear retainer ring. The retainer ring helps to lock the insulin cartridge into place in the pump’s reservoir compartment. If the cartridge is not locked firmly into place, under or over insulin delivery may occur. In a separate update, FDA said Medtronic expanded an August 2018 recall of re

Continuous Rhythm Monitoring Reveals Strong Short-Term Risk Association Between Atrial Fibrilation Episodes and Ischemic Stroke
Mon, 04 Oct 2021 14:00:00 +0000
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the publication of a study demonstrating, through the use of a Medtronic continuous rhythm monitoring device, that atrial fibrillation (AF) is directly and transiently associated with ischemic stroke. The findings were published online on September 29 in JAMA Cardiology.

Is Medtronic plc (NYSE:MDT) Popular Amongst Institutions?
Sat, 02 Oct 2021 14:52:22 +0000
A look at the shareholders of Medtronic plc ( NYSE:MDT ) can tell us which group is most powerful. Institutions often…

The Zacks Analyst Blog Highlights: Medtronic, Boston Scientific Corp, Catalent, Baxter International and Hill-Rom Holdings
Fri, 01 Oct 2021 10:46:10 +0000
The Zacks Analyst Blog Highlights: Medtronic, Boston Scientific Corp, Catalent, Baxter International and Hill-Rom Holdings

Medtronic Expands Minimally Invasive Spine Surgery Ecosystem with Next-Generation Spinal Technologies
Thu, 30 Sep 2021 14:00:00 +0000
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the latest additions to its minimally invasive spine surgery ecosystem, making it the only company to combine spinal implants, biologics, navigation, robotics, and AI-powered data to surgeons and patients.

Be Sociable, Share!

Related Posts